Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naren P Rao

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Indian Journal of Psychiatry|December 11, 2012
Pathogenetic and therapeutic perspectives on neurocognitive models in psychiatry: A synthesis of behavioral, brain imaging, and biological studiesNaren P Rao
Asian Journal of Psychiatry|October 12, 2012
Conference proceedings: 62nd annual national conference of Indian psychiatric societyNaren P Rao
Expert Opinion on Investigational Drugs|May 4, 2013
Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trialsNaren P Rao, Gary Remington
Indian Journal of Psychiatry|February 13, 2019
Neurocognitive deficits in obsessive-compulsive disorder: A selective reviewSatish Suhas, Naren P Rao
Expert Opinion on Pharmacotherapy|December 21, 2013
Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trialsNaren P Rao, Gary Remington
Schizophrenia Research|November 27, 2021
Personal protective equipment in the emergency room and schizophrenia - Implications beyond safetySatish Suhas, Naren P Rao
International Review of Psychiatry (Abingdon, England)|June 23, 2016
Special supplement: Yoga and mental healthJagadisha Thirthalli, Naren P Rao
The Lancet. Psychiatry|May 23, 2021
Psychosis and COVID-19: is it time to pre-emptively revise advanced directives?Satish Suhas, Naren P Rao
Psychiatry Research. Neuroimaging|January 4, 2019
Resting-state anticorrelated networks in SchizophreniaShukti Ramkiran, Abhinav Sharma, Naren P Rao
Asian Journal of Psychiatry|December 3, 2014
Association between antipsychotic-induced metabolic side-effects and clinical improvement: a review on the evidence for metabolic threshold: author's responseEesha Sharma, Naren P Rao, Ganesan Venkatasubramanian
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Indian Journal of Psychiatry|December 11, 2012
Pathogenetic and therapeutic perspectives on neurocognitive models in psychiatry: A synthesis of behavioral, brain imaging, and biological studiesNaren P Rao
Asian Journal of Psychiatry|October 12, 2012
Conference proceedings: 62nd annual national conference of Indian psychiatric societyNaren P Rao
Expert Opinion on Investigational Drugs|May 4, 2013
Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trialsNaren P Rao, Gary Remington
Indian Journal of Psychiatry|February 13, 2019
Neurocognitive deficits in obsessive-compulsive disorder: A selective reviewSatish Suhas, Naren P Rao
Expert Opinion on Pharmacotherapy|December 21, 2013
Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trialsNaren P Rao, Gary Remington
Schizophrenia Research|November 27, 2021
Personal protective equipment in the emergency room and schizophrenia - Implications beyond safetySatish Suhas, Naren P Rao
International Review of Psychiatry (Abingdon, England)|June 23, 2016
Special supplement: Yoga and mental healthJagadisha Thirthalli, Naren P Rao
The Lancet. Psychiatry|May 23, 2021
Psychosis and COVID-19: is it time to pre-emptively revise advanced directives?Satish Suhas, Naren P Rao
Psychiatry Research. Neuroimaging|January 4, 2019
Resting-state anticorrelated networks in SchizophreniaShukti Ramkiran, Abhinav Sharma, Naren P Rao
Asian Journal of Psychiatry|December 3, 2014
Association between antipsychotic-induced metabolic side-effects and clinical improvement: a review on the evidence for metabolic threshold: author's responseEesha Sharma, Naren P Rao, Ganesan Venkatasubramanian
Pageof 14